Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox effect and duration study for bruxism
RBR-39ght5Completed
- Sponsor
- Universidade Ibirapuera
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in bruxism (2 arms), sponsored by Universidade Ibirapuera. Started Jul 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
bruxism
Beyond the preview
Go deeper on RBR-39ght5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-39ght5.